All News

Found 2,671 articles

• Strategic Research Institute Release: 25 Different Pharma Companies To Present At Conference On Patient-Level Data For Improving Marketing Effectiveness To Take Place April 4-5, 2006 New Brunswick, N.J.

  1/26/2006

• Strategic Research Institute Release: Pharmaceutical Marketing & Sales (PMS) 2006 Show Unveiled And To Take Place April 4-5 In New Brunswick, NJ

  1/24/2006

• Vertex Pharmaceuticals Incorporated Announces The Date Of Its Fourth Quarter And Full Year 2005 Financial Results Conference Call And Webcast

  1/18/2006

• Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research

  1/16/2006

• Vertex Pharmaceuticals Incorporated And Cystic Fibrosis Foundation Therapeutics, Inc. Extend Collaboration For Cystic Fibrosis Drug Research

  1/12/2006

• ActivBiotics And Metaphore Pharmaceuticals, Inc. Complete Merger Creating Late-Stage Company Addressing Serious Infections And Inflammation

  1/11/2006

• Vertex Pharmaceuticals Incorporated Hepatitis C Drug Effective In Small Study

  1/9/2006

• The Day In Review: Biotech Hits Historic Highs

  1/9/2006

• Avalon Pharmaceuticals Initiates AVN944 Phase I Clinical Trial In Cancer Patients

  1/9/2006

• Vertex Pharmaceuticals Incorporated Announces Key Business Objectives For 2006 At 24th Annual JPMorgan Healthcare Conference

  1/9/2006

• Boston Life Sciences Announces Appointment Of Senior Vice President, Regulatory Affairs And Quality

  1/6/2006

• Vertex Pharmaceuticals Incorporated Announces Webcast Of Its Presentation At The 24th Annual JPMorgan Healthcare Conference

  1/4/2006

• GlaxoSmithKline And Vertex Pharmaceuticals Incorporated Announce Presentation Of Data Supporting Development Of Investigational HIV Protease Inhibitor Brecanavir

  12/16/2005

• GlaxoSmithKline And Vertex Pharmaceuticals Incorporated Announce New Collaboration To Develop And Commercialize VX-409, A Novel Compound For The Treatment Of Pain

  12/13/2005

• The Day In Review: Insmed Wins Approval For Growth Drug

  12/13/2005

• Vertex Pharmaceuticals Incorporated Expects $19.5 Million In Milestone Payments

  12/8/2005

• FDA Grants Fast Track Designation To Vertex Pharmaceuticals Incorporated's Investigational Oral Hepatitis C Virus Protease Inhibitor VX-950

  12/8/2005

• Galapagos Extends Services Deal With Amgen

  12/7/2005

• Vertex Pharmaceuticals Incorporated Announces That VX-680 Demonstrates Effect On Clinically Relevant Biomarker In Phase I Cancer Study

  12/7/2005

• Vertex Pharmaceuticals Incorporated Announces Start Of Phase II Clinical Development For Investigational Oral Hepatitis C Virus Protease Inhibitor VX-950

  12/5/2005